Literature DB >> 30332296

State of the Art: Machine Learning Applications in Glioma Imaging.

Eyal Lotan1, Rajan Jain1, Narges Razavian1,2, Girish M Fatterpekar1, Yvonne W Lui1.   

Abstract

OBJECTIVE: Machine learning has recently gained considerable attention because of promising results for a wide range of radiology applications. Here we review recent work using machine learning in brain tumor imaging, specifically segmentation and MRI radiomics of gliomas.
CONCLUSION: We discuss available resources, state-of-the-art segmentation methods, and machine learning radiomics for glioma. We highlight the challenges of these techniques as well as the future potential in clinical diagnostics, prognostics, and decision making.

Entities:  

Keywords:  brain lesion segmentation; deep learning; glioma; machine learning; radiomics

Mesh:

Year:  2018        PMID: 30332296     DOI: 10.2214/AJR.18.20218

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  23 in total

1.  Can my computer tell me if this tumor is IDH mutated?

Authors:  Timothy J Kaufmann; Bradley J Erickson
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

2.  Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma.

Authors:  E George; E Flagg; K Chang; H X Bai; H J Aerts; M Vallières; D A Reardon; R Y Huang
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-28       Impact factor: 3.825

3.  Development and Practical Implementation of a Deep Learning-Based Pipeline for Automated Pre- and Postoperative Glioma Segmentation.

Authors:  E Lotan; B Zhang; S Dogra; W D Wang; D Carbone; G Fatterpekar; E K Oermann; Y W Lui
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-02       Impact factor: 3.825

4.  An Improved Machine Learning Model for Diagnostic Cancer Recognition Using Artificial Intelligence.

Authors:  N Arivazhagan; J Venkatesh; K Somasundaram; K Vijayalakshmi; S Sathiya Priya; M Suresh Thangakrishnan; K Senthamilselvan; B Lakshmi Dhevi; D Vijendra Babu; S Chandragandhi; Fekadu Ashine Chamato
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

5.  Automated Meningioma Segmentation in Multiparametric MRI : Comparable Effectiveness of a Deep Learning Model and Manual Segmentation.

Authors:  Kai Roman Laukamp; Lenhard Pennig; Frank Thiele; Robert Reimer; Lukas Görtz; Georgy Shakirin; David Zopfs; Marco Timmer; Michael Perkuhn; Jan Borggrefe
Journal:  Clin Neuroradiol       Date:  2020-02-14       Impact factor: 3.649

Review 6.  Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.

Authors:  Fabrício Guimarães Gonçalves; Sanjeev Chawla; Suyash Mohan
Journal:  J Magn Reson Imaging       Date:  2020-03-19       Impact factor: 4.813

Review 7.  Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Authors:  Ashirbani Saha; Samantha Tso; Jessica Rabski; Alireza Sadeghian; Michael D Cusimano
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

8.  Meningioma MRI radiomics and machine learning: systematic review, quality score assessment, and meta-analysis.

Authors:  Lorenzo Ugga; Teresa Perillo; Renato Cuocolo; Arnaldo Stanzione; Valeria Romeo; Roberta Green; Valeria Cantoni; Arturo Brunetti
Journal:  Neuroradiology       Date:  2021-03-02       Impact factor: 2.804

9.  Development and Validation of a Deep Learning-Based Model to Distinguish Glioblastoma from Solitary Brain Metastasis Using Conventional MR Images.

Authors:  I Shin; H Kim; S S Ahn; B Sohn; S Bae; J E Park; H S Kim; S-K Lee
Journal:  AJNR Am J Neuroradiol       Date:  2021-03-18       Impact factor: 4.966

Review 10.  Imaging-Genomics in Glioblastoma: Combining Molecular and Imaging Signatures.

Authors:  Dongming Liu; Jiu Chen; Xinhua Hu; Kun Yang; Yong Liu; Guanjie Hu; Honglin Ge; Wenbin Zhang; Hongyi Liu
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.